Search by Drug Name or NDC

    NDC 00169-1833-02 Novolin 100 [iU]/mL Details

    Novolin 100 [iU]/mL

    Novolin is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN HUMAN.

    Product Information

    NDC 00169-1833
    Product ID 0169-1833_46700b71-3f26-4aaa-8eb7-6ceeeb515c79
    Associated GPIs 27104010002005
    GCN Sequence Number 001723
    GCN Sequence Number Description insulin regular, human VIAL 100/ML INJECTION
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 11642
    HICL Sequence Number 000768
    HICL Sequence Number Description INSULIN REGULAR, HUMAN
    Brand/Generic Brand
    Proprietary Name Novolin
    Proprietary Name Suffix R
    Non-Proprietary Name Human Insulin
    Product Type HUMAN OTC DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN HUMAN
    Labeler Name Novo Nordisk
    Pharmaceutical Class Insulin [CS], Insulin [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA019938
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-1833-02 (00169183302)

    NDC Package Code 0169-1833-02
    Billing NDC 00169183302
    Package 1 VIAL in 1 CARTON (0169-1833-02) / 10 mL in 1 VIAL
    Marketing Start Date 1991-06-25
    NDC Exclude Flag N
    Pricing Information N/A